EAACI Congress 2025 – Breaking Boundaries in Allergy,
ZURICH, March 18, 2025 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) proudly presents the EAACI...
Immunology and Allergy
Editorial: Immune responses in the progression of allergy and asthma
The pathogeneses of allergies and asthma are characterized by chronic airway inflammation, hyperresponsiveness, and airway remodeling, contributed to by heterogeneous,...
Burks and Keet Publish Editorial on Oral Immunotherapy for High Threshold Peanut Allergy
Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine, professor of pediatrics, Division of...
EAACI Congress 2025 – Breaking Boundaries in Allergy,
ZURICH, March 18, 2025 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) proudly presents the EAACI...
Omalizumab treats multi-food allergy better than oral immunotherapy
News ReleaseMonday, March 3, 2025 High rate of oral immunotherapy side effects in NIH trial explains superiority of omalizumab.A clinical...
American Academy of Allergy, Asthma AND Immunology, Feb. 28-March 3
The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from Feb. 28 to March 3 in San...
